Internship

Intern – Informatics

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$22 - $45Hourly

San Bruno, CA, USA

Paid internship requiring on-site presence at South San Francisco headquarters for approximately 12 weeks.

Category
Bioinformatics
Biology & Biotech
Required Skills
Python
JavaScript
Git
SQL
Postgres
AWS
REST APIs
Oracle
Data Analysis
HTML/CSS
Requirements
  • Currently enrolled undergraduate student with a computer science major or emphasis in such
  • Strong programming fundamentals and experience with modern development tools
  • Highly focused, organized, detail oriented and motivated team player with good time management skills
  • Experience with software development, data management, and data analysis
  • Excellent written and verbal communication skills
  • Ability to solve problems independently using documentation, online resources, and best practices
  • Interest in biotechnology systems and scientific software solutions
  • Experience with Python, and/or JavaScript/HTML web applications
  • Experience with AWS cloud services (S3, Lambda, EC2)
  • Experience with SQL and database technologies (PostgreSQL or Oracle)
  • Knowledge of version control systems (Git)
  • Understanding of RESTful APIs and web services
Responsibilities
  • You will be tasked with one or more projects related to systems and data to support biopharmaceutical scientists.
  • You will apply modern software engineering principles while working on tasks ranging from software system migration, system configuration, data analysis, development of scripts/applications, and potentially machine learning solutions specifically for drug discovery scientists.
  • You will collaborate with informatics personnel and scientists to achieve project goals.

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, depending on the condition being treated. For example, they are working on drugs for heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. What sets Cytokinetics apart from competitors is their specific focus on muscle-related conditions and their extensive pipeline of drugs currently in clinical trials. The company's goal is to bring effective treatments to market that address the unmet needs of patients suffering from these debilitating diseases.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.

Help us improve and share your feedback! Did you find this helpful?